Search clinical trials for: PF-07062119
Total 1610 results
-
PfizerCompleted
-
PfizerTerminatedBreast Cancer MetastaticUnited States, Spain, Belgium, Italy
-
PfizerCompletedAlzheimer's DiseaseSweden
-
Sun Yat-sen UniversityActive, not recruitingNasopharyngeal CarcinomaChina
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
Jessa HospitalRecruitingHearing Loss, Sensorineural | DFNA9 | Radiology | Bilateral Vestibular DeficiencyBelgium
-
Abbott Rapid DxBill and Melinda Gates FoundationCompleted
-
BiogenCompletedSchizophreniaUnited States
-
University of California, BerkeleyAlcon ResearchCompleted
-
PfizerCompleted
-
Sun Yat-sen UniversityActive, not recruiting
-
University of Colorado, DenverThe Leukemia and Lymphoma SocietyCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in RemissionUnited States
-
PfizerRecruitingShingles | Human | Herpes Zoster InfectionUnited States
-
PfizerTerminatedEczema | Atopic Dermatitis | Eczema, Atopic | Atopic Dermatitis, UnspecifiedUnited States, Canada, Czechia, Poland
-
PfizerTerminatedDilated Cardiomyopathy | Lamin A/C Gene MutationUnited States, Spain, Canada, Belgium, Italy, Argentina, Mexico, Netherlands, Norway, United Kingdom
-
ShireTerminatedCrohn's DiseaseSpain, United States, Korea, Republic of, Hungary, Turkey, Belgium, Bulgaria, Argentina, Greece, New Zealand, Bosnia and Herzegovina, Colombia, Estonia, Ireland, Japan, Lebanon, Mexico, Portugal, Slovakia, Ukraine
-
PfizerJANSSEN Alzheimer Immunotherapy Research & Development, LLCCompletedAlzheimer's DiseaseUnited States, Korea, Republic of
-
Conatus Pharmaceuticals Inc.CompletedKidney Diseases | Renal Insufficiency | Renal Impairment | Kidney DiseaseUnited States
-
PfizerCompletedPhiladelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)Singapore
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; Johns Hopkins University and other collaboratorsCompletedCannabis Use DisorderUnited States
-
M.D. Anderson Cancer CenterPfizer; ISA Pharmaceuticals B.V.CompletedOropharyngeal Cancer | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and PharynxUnited States
-
PfizerCompletedNeoplasms by Histologic TypeUnited States, Italy
-
PfizerBristol-Myers SquibbCompletedHealthySingapore, Belgium
-
Taisho Pharmaceutical Co., Ltd.Completed
-
PfizerCompletedHepatic ImpairmentUnited States
-
PfizerCompletedHealthy | Otherwise Healthy Volunteers With Mild or Moderate Hepatic DysfunctionUnited States
-
PfizerCompletedDermatitis, AtopicUnited States, Hungary, Canada, Germany, Australia, Czechia, Poland, United Kingdom
-
PfizerCompletedAtopic DermatitisUnited States, Canada
-
PfizerCompletedDermatitis, AtopicChina, United States, Australia, Poland, Hungary, Korea, Republic of, Germany, Bulgaria, Canada, Czechia, Japan, Latvia, United Kingdom
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Canada, Spain, Belgium, United Kingdom, Australia, Japan, France, Germany, Poland
-
PfizerCompletedTransthyretin Amyloid CardiomyopathyChina
-
PfizerCompletedReduction in Severity of Skin ScarringUnited States
-
PfizerYale UniversityCompleted
-
Cerevel Therapeutics, LLCRecruitingHealthy Participants | Alzheimer's Disease DementiaUnited States
-
University of OxfordCompletedTreatment Resistant Depression | Depression, UnipolarUnited Kingdom
-
PfizerTerminatedHealthy VolunteersBelgium
-
PfizerPfizerRecruitingSickle Cell DiseaseUnited States, Nigeria, Kenya, Lebanon
-
PfizerTerminatedBreast Neoplasms | Ovarian Neoplasms | Endometrial NeoplasmsUnited States, Puerto Rico
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerCompleted
-
PfizerCompletedAttention Deficit Hyperactivity DisorderUnited States
-
PfizerCompleted
-
PfizerCompletedHealthy VolunteersUnited States
-
Jules Bordet InstituteWithdrawnBreast CancerBelgium, France
-
PfizerCompleted